These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 20728280

  • 1. Edaravone: a new therapeutic approach for the treatment of acute stroke.
    Kikuchi K, Kawahara K, Miyagi N, Uchikado H, Kuramoto T, Morimoto Y, Tancharoen S, Miura N, Takenouchi K, Oyama Y, Shrestha B, Matsuda F, Yoshida Y, Arimura S, Mera K, Tada K, Yoshinaga N, Maenosono R, Ohno Y, Hashiguchi T, Maruyama I, Shigemori M.
    Med Hypotheses; 2010 Dec; 75(6):583-5. PubMed ID: 20728280
    [Abstract] [Full Text] [Related]

  • 2. The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: a combination therapy study with tissue plasminogen activator.
    Lapchak PA, Zivin JA.
    Exp Neurol; 2009 Jan; 215(1):95-100. PubMed ID: 18851964
    [Abstract] [Full Text] [Related]

  • 3. Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4.
    Kikuchi K, Tancharoen S, Matsuda F, Biswas KK, Ito T, Morimoto Y, Oyama Y, Takenouchi K, Miura N, Arimura N, Nawa Y, Meng X, Shrestha B, Arimura S, Iwata M, Mera K, Sameshima H, Ohno Y, Maenosono R, Tajima Y, Uchikado H, Kuramoto T, Nakayama K, Shigemori M, Yoshida Y, Hashiguchi T, Maruyama I, Kawahara K.
    Biochem Biophys Res Commun; 2009 Dec 25; 390(4):1121-5. PubMed ID: 19737535
    [Abstract] [Full Text] [Related]

  • 4. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
    Ueno Y, Zhang N, Miyamoto N, Tanaka R, Hattori N, Urabe T.
    Neuroscience; 2009 Aug 18; 162(2):317-27. PubMed ID: 19409967
    [Abstract] [Full Text] [Related]

  • 5. Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5).
    Yamaguchi T, Awano H, Matsuda H, Tanahashi N, PROTECT4.5 Investigators.
    J Stroke Cerebrovasc Dis; 2017 Apr 18; 26(4):756-765. PubMed ID: 27887792
    [Abstract] [Full Text] [Related]

  • 6. Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial).
    Shinohara Y, Saito I, Kobayashi S, Uchiyama S.
    Cerebrovasc Dis; 2009 Apr 18; 27(5):485-92. PubMed ID: 19321945
    [Abstract] [Full Text] [Related]

  • 7. Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients--a preliminary study.
    Kimura K, Aoki J, Sakamoto Y, Kobayashi K, Sakai K, Inoue T, Iguchi Y, Shibazaki K.
    J Neurol Sci; 2012 Feb 15; 313(1-2):132-6. PubMed ID: 21967833
    [Abstract] [Full Text] [Related]

  • 8. Effects of edaravone on early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator.
    Wada T, Yasunaga H, Inokuchi R, Horiguchi H, Fushimi K, Matsubara T, Nakajima S, Yahagi N.
    J Neurol Sci; 2014 Oct 15; 345(1-2):106-11. PubMed ID: 25085762
    [Abstract] [Full Text] [Related]

  • 9. Stroke in a child safely treated with intravenous tissue plasminogen activator and edaravone, a free radical scavenger.
    Baba H, Sugimori H, Nanishi E, Nagata H, Lee S, Kuwashiro T, Hashizume M.
    J Stroke Cerebrovasc Dis; 2012 Nov 15; 21(8):903.e5-8. PubMed ID: 21421331
    [Abstract] [Full Text] [Related]

  • 10. Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion.
    Toyoda K, Fujii K, Kamouchi M, Nakane H, Arihiro S, Okada Y, Ibayashi S, Iida M.
    J Neurol Sci; 2004 Jun 15; 221(1-2):11-7. PubMed ID: 15178207
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells.
    Kikuchi K, Kawahara K, Tancharoen S, Matsuda F, Morimoto Y, Ito T, Biswas KK, Takenouchi K, Miura N, Oyama Y, Nawa Y, Arimura N, Iwata M, Tajima Y, Kuramoto T, Nakayama K, Shigemori M, Yoshida Y, Hashiguchi T, Maruyama I.
    J Pharmacol Exp Ther; 2009 Jun 15; 329(3):865-74. PubMed ID: 19293391
    [Abstract] [Full Text] [Related]

  • 14. Effects of edaravone, a free radical scavenger, on serum levels of inflammatory biomarkers in acute brain infarction.
    Isahaya K, Yamada K, Yamatoku M, Sakurai K, Takaishi S, Kato B, Hirayama T, Hasegawa Y.
    J Stroke Cerebrovasc Dis; 2012 Feb 15; 21(2):102-7. PubMed ID: 21215657
    [Abstract] [Full Text] [Related]

  • 15. Edaravone - citicoline comparative study in acute ischemic stroke (ECCS-AIS).
    Mitta M, Goel D, Bansal KK, Puri P.
    J Assoc Physicians India; 2012 Nov 15; 60():36-8. PubMed ID: 23767201
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Attenuation of axonal injury and oxidative stress by edaravone protects against cognitive impairments after traumatic brain injury.
    Ohta M, Higashi Y, Yawata T, Kitahara M, Nobumoto A, Ishida E, Tsuda M, Fujimoto Y, Shimizu K.
    Brain Res; 2013 Jan 15; 1490():184-92. PubMed ID: 22982593
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.